Jul 14, 2026
18 MIN READ

NAD+ Mounjaro Side Effects — What Users Must Know

Tirzepatide is a dual GLP-1 and GIP receptor agonist that helps with weight loss, but users often experience nausea, vomiting, and gastrointestinal changes. Understanding these effects and how to manage them is essential for treatment success with PlexusDx.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jul 14, 2026
18 MIN READ

nad+ mounjaro side effects — what users must know — PlexusDx GLP-1 education

Last reviewed: July 14, 2026

Last updated: July 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide injection activates two hormone pathways—GLP-1 and GIP receptors—to reduce appetite and improve blood sugar control, but gastrointestinal side effects occur in most patients during the first weeks of treatment. These effects typically peak in the first two to four weeks and often improve as your body adjusts. PlexusDx provides tirzepatide through licensed 503A compounding pharmacies, and our clinical team helps you understand what to expect and how to manage symptoms safely.

Start a NAD+ protocol with PlexusDx

One all-inclusive price covers your online provider visit, prescription, medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.

Start your intake →

Common Tirzepatide Injection Side Effects

The most frequently reported side effects of tirzepatide involve the digestive system because the medication slows stomach emptying and signals satiety to the brain. Nausea affects approximately 25–35% of patients during the first month, while vomiting occurs in 10–15% of users. Constipation and diarrhea both appear in clinical trials, with constipation more common early in treatment and diarrhea potentially emerging after several weeks as your system adapts.

Appetite suppression is intentional but can feel uncomfortable if you are not prepared for it. Many patients report feeling full after small amounts of food or losing interest in foods they previously enjoyed. Abdominal pain, bloating, and changes in taste perception also occur but typically subside within 4–8 weeks. These gastrointestinal changes are dose-dependent, meaning higher doses tend to produce stronger effects, but PlexusDx's approach starts conservatively to minimize symptom burden.

How Long Do Tirzepatide Side Effects Last

Most patients experience peak nausea and vomiting during the first two weeks after starting tirzepatide, with symptoms improving significantly by week four in approximately 70% of users. Individual timelines vary based on genetics, baseline gut health, and how quickly your provider increases your dose. Constipation may persist longer than nausea—some patients manage it throughout treatment—while appetite suppression typically becomes less noticeable as your body adjusts to the medication's presence.

The Precision Peptide Genetic Test offered by PlexusDx analyzes variants in your GLP1R and GIPR genes, which influence how your body responds to tirzepatide activation. Users with certain genetic profiles may experience faster symptom resolution or may require a more gradual dose escalation. Keeping a symptom diary during your first month helps your PlexusDx care team personalize your treatment timeline and identify whether symptoms are improving as expected.

Managing Tirzepatide Nausea and Gastrointestinal Effects

Eating small, frequent meals—about 4–6 meals per day of 200–300 calories each—helps prevent nausea and takes advantage of your reduced appetite without forcing large portions. Focus on protein-rich, low-fat foods like grilled chicken, fish, eggs, and Greek yogurt, which are easier to digest and support muscle preservation during weight loss. Ginger tea, peppermint, and staying hydrated with water or electrolyte drinks can reduce nausea intensity, while avoiding greasy, spicy, and overly sweet foods prevents symptom flares.

For constipation, increase water intake to at least 80–100 ounces daily, add fiber gradually (psyllium husk or ground flaxseed), and move your body with light exercise such as walking for 20–30 minutes most days. Over-the-counter stool softeners like docusate are safe alongside tirzepatide, though laxatives should be used sparingly. If nausea persists beyond four weeks or prevents you from eating enough to maintain energy, contact your PlexusDx care team—they may recommend dose spacing adjustments or prescription anti-nausea medication.

Serious Side Effects and When to Seek Medical Care

While most tirzepatide side effects are mild to moderate, certain symptoms require immediate medical attention: severe abdominal pain, persistent vomiting lasting more than a few hours, signs of pancreatitis (upper abdominal pain radiating to the back), rapid heart rate, or dizziness. Tirzepatide is contraindicated in personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, so disclose your complete medical history to PlexusDx before starting treatment. Dehydration from vomiting or diarrhea can develop quickly, especially in warm climates, so monitor your urine color and thirst levels closely.

Gallbladder issues occur at slightly higher rates in patients losing weight rapidly on GLP-1 or GIP agonists, presenting as sudden right-sided abdominal pain, fever, or nausea after eating fatty foods. Low blood sugar (hypoglycemia) is rare unless you combine tirzepatide with insulin or sulfonylureas, but trembling, sweating, or confusion warrant immediate evaluation. PlexusDx's licensed compounding pharmacies provide tirzepatide at $289 per month with no flat per-compound pricing increases—meaning your dose may go up without your cost changing—making ongoing monitoring and communication with your care team financially accessible.

Tirzepatide Side Effects vs. Semaglutide Comparison

Tirzepatide activates both GLP-1 and GIP receptors, whereas semaglutide targets only GLP-1, making tirzepatide more potent for appetite suppression but sometimes triggering stronger gastrointestinal effects. Head-to-head trials show tirzepatide produces slightly higher rates of nausea (28% vs. 20%) and vomiting (11% vs. 5%) compared to semaglutide in the first month, though both medications typically follow the same symptom timeline. Weight loss efficacy is approximately 10–15% greater with tirzepatide at equivalent doses, which some patients feel justifies managing slightly stronger initial side effects.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, and GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

When do tirzepatide side effects start, and how long until they go away?

Nausea and gastrointestinal symptoms typically begin within 24–48 hours of your first injection and peak during weeks 1–2. Most patients see significant improvement by week 4, though some experience mild effects throughout treatment. Starting at a low dose and increasing gradually helps minimize symptom intensity; PlexusDx's approach prioritizes tolerability so you can stick with treatment long-term.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx's Precision Peptide Genetic Test analyzes your GLP1R (rs6923761) and GIPR (rs1800437) variants, which influence receptor sensitivity and side-effect risk. Patients with certain genetic profiles may experience faster symptom resolution or require slower dose escalation. This personalized insight, available for $99 after your first month, helps your care team tailor your treatment plan to your unique biology.

Is tirzepatide safe to use long-term, or are side effects a sign to stop?

Tirzepatide is designed for long-term weight management, and mild gastrointestinal side effects that improve after a few weeks are not a reason to discontinue. However, persistent severe nausea, vomiting, or signs of pancreatitis require immediate medical evaluation. PlexusDx care teams monitor your progress and side effects throughout treatment to ensure safety and effectiveness at your current dose.

What foods should I avoid while taking tirzepatide to prevent nausea?

Avoid high-fat fried foods, spicy dishes, caffeine on an empty stomach, and overly sweet desserts, which trigger nausea in most tirzepatide users. Stick to lean proteins, non-starchy vegetables, and whole grains in small portions. Eating slowly and staying hydrated throughout the day also reduces gastrointestinal distress and helps your body tolerate the medication as it adjusts.

How much does tirzepatide cost at PlexusDx, and does the price change with higher doses?

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan), with no flat per-compound pricing increases—meaning your dose may go up without your cost changing. All compounding is performed by licensed 503A pharmacies serving all 50 states with no insurance required, and treatment is HSA/FSA eligible. Contact PlexusDx to confirm availability in your state and begin your personalized weight loss therapy.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves